更正：梁等人。柳氮磺胺吡啶通过靶向KRAS/MMP7/CD44信号通路抑制结直肠癌干性和转移的治疗潜力的临床前鉴定。2022年，，377。
Correction: Leung et al. Preclinical Identification of Sulfasalazine's Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling. 2022, , 377.
作者信息
Leung Wai-Hung, Shih Jing-Wen, Chen Jian-Syun, Mokgautsi Ntlotlang, Wei Po-Li, Huang Yan-Jiun
机构信息
Division of Colon and Rectal Surgery, Department of Surgery, Mackay Memorial Hospital, No. 92, Sec. 2, Zhongshan N. Rd., Taipei 10449, Taiwan.
Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 11031, Taiwan.
出版信息
Biomedicines. 2025 Feb 21;13(3):547. doi: 10.3390/biomedicines13030547.
Abstract
In the original publication, there is a mistake in Figure 11B as published [...].
摘要
在最初发表的文献中，已发表的图11B存在一处错误[……]。
Zotero 插件